| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |